The US FDA has approved Journavx, a new pain reliever without the risks for addiction or overdose linked to drugs like Vicodin and OxyContin.

Exposure to cold in the Netherlands and to heat in Spain appears to be associated with more psychiatric symptoms among adolescents.

Heat-related deaths are expected to climb throughout Europe this century due to climate change, according to study findings.

Patients colonized with AMR pathogens showed high risk for infection with the same pathogen for up to 2 years, indicating a time window for decolonization interventions.

Mepolizumab reduces asthma exacerbations among real-world patients with severe asthma and an eosinophilic phenotype.

Distribution of prescribed opioid analgesics is lower in majority non-White vs majority White communities across all levels of socioeconomic deprivation.

Adult and pediatric patients who received 2023-2024 influenza vaccines exhibited reduced risk for influenza-associated encounters across care settings.

Children with COVID-19 vs RSV or influenza infections are at an increased risk of developing cardiovascular complications.

Respiratory illnesses that progress to pediatric asthma exacerbations are linked to a steeper rise in interferon expression in airways and blood.

Neoantigen-targeting PCVs are highly immunogenic in high-risk clear cell RCC and can target key driver mutations and induce antitumor immunity.

Substantial gaps in COVID-19 vaccination were identified among people who inject drugs in San Francisco, California in 2022.

In COPD, muscular atrophy is a significant risk factor for death and may prolong patients’ hospital length of stay.